Cryo-Save Share Discussion Threads

[masurenguy] 08/10/2009 08:15

LOL - chart looks AMAZING ! :O)

[masurenguy] 08/10/2009 07:21

RNS Number : 4183A
Cryo-Save Group NV
08 October 2009

Share Consolidation

Cryo-Save Group N.V. (AIM: CRYO, 'Cryo-Save' or 'the Company'), Europe's leading stem cell bank, confirms that pursuant to the passing of the relevant resolutions at an EGM of the Company held on 5 October 2009, and as notified on that day, the proposed 5:1 share consolidation has this morning become effective. As result of the share consolidation the Company's authorised share capital now comprises 9,639,191 ordinary shares of €0.10 each; the associated depository interests for these ordinary shares will commence trading at 8:00am today under ISIN NL0009272137.

About Cryo-Save

With more than 115,000 samples saved, Cryo-Save is the leading stem cell bank in Europe and one of the fastest growing in the world. Driven by its international business strategy, Cryo-Save is now represented in 38 countries on three continents and has state-of-the-art processing facilities in Belgium, Germany, Dubai, India and France (under construction). Cryo-Save sets the highest quality standards in stem cell storage, as it aims to make an important contribution to conquer possible life-threatening diseases in the future. As a service to the public, Cryo-Save offers a Cost-free Family Donation Programme, free of charge, to families wishing to store their newborn's umbilical cord blood stem cells for a family member diagnosed with a life-threatening disease treatable by stem cells. The company is committed to further improve stem cell cryopreservation techniques, by participating in European Commission funded projects, in Universities and Hospitals.

[dannys] 06/10/2009 10:55

looking good today!!!!
also think it will only be a matter of time before this company becomes a takeover target.
hope not as would like to keep these for the very long term.

[masurenguy] 06/10/2009 07:32

Wilmdav - 23 Sep'09 - 75: First a couple of questions to anyone.
Q1. If they de-list from AIM, what happens to shareholders who trade through a UK broker that does not deal in stocks quoted outside AIM, Plus & LSE? Presumably one would have to sell before de-listing.
Q2. Why do they not operate in the UK?

Wilmdav - sorry for not responding to your questions earlier but I hadn't recently revisited this thread until today.

1.If they do delist from AIM then they will still be tradable through most brokers but they would set up a separate account denominated in Euros. I've checked this with my main broker (Barclays) and there is no problem doing this whatsoever. If your broker does not deal in stocks outside the UK then all you would need to do is to open another account with one that does and transfer the shares which would be converted from £sterling held in a Euro denominated account.

2. They do operate in the UK, but on a small scale at the moment and all of the samples are stored in Belgium. They have focused on other European (and India) at this stage since they find NHS hospitals rather difficult to deal with in this context.

[masurenguy] 06/10/2009 07:17

RNS Number : 2736A
Cryo-Save Group NV
06 October 2009

New storage record - 7,300 samples stored in Q3 2009, 12% up on Q3 2008 and 4% up on Q2 2009M/b>

Cryo-Save Group N.V. Europe's leading stem cell bank, has published its Q3 2009 sample storage numbers for the quarter to 30 September 2009. 7,300 samples were stored in Q3 2009, up 12% over Q3 2008 (6,500 samples), and up 4% over Q2 2009 (7,000 samples). This is again an all time record for the Group. Since the introduction mid 2008 of the additional service to process and store stem cells from the umbilical cord itself, the Group has stored around 2,500 cord samples.

Separately the development of the processing and storage facility in Lyon, France is progressing. The Group aims to complete the installation, which will cost around €1 million, in early 2010. Subject to regulatory clearance, the Group expects to start using the Lyon facility in the first half of 2010. In the meantime Cryo-Save continues to sell its services to French customers via its Swiss operation.

Marc Waeterschoot, Chief Executive, commented: 'The positive trend set during the first half of this year has continued during the third quarter. Although we were slightly impacted by the normal slower summer sales in our main markets in Southern Europe. 'This growth compared to the second quarter, which was our best quarter ever, underpins our strong position for sustainable growth across a number of countries. Coupled with the further roll out of our umbilical cord services to more countries and the expected growth of sales, especially in India and France, we remain confident for a good fourth quarter.'

[dannys] 25/9/2009 18:33

not sure how many brokers do not trade european exchanges so should not really be a problem.
as for why they do not operate in uk you could always email and ask these questions as i,ve always had a quick reply to questions i have asked.

[wilmdav] 23/9/2009 19:48

Masurenguy (who mentioned CRYO to me on another board)

I have had quite a good look at this one but only through the rear view mirror.

First a couple of questions to anyone.

Q1. If they de-list from AIM, what happens to shareholders who trade through a UK broker that does not deal in stocks quoted outside AIM, Plus & LSE? Presumably one would have to sell before de-listing.

Q2. Why do they not operate in the UK?

Accounts are a bit of a mess in some respects. Treatment of 'underlying' earnings is inconsistent when comparing one report with another, e.g. 2008 adjusts for amortisation (€1.1m), whereas H1-09 does not(€0.6m). There are other instances relating to one off costs. Doesn't strike me as an attempt to deceive, rather that the FD has not yet got the hang of reporting to UK investors.

In one respect it did not matter because for this type of share I'm more interested in basic earnings than 'underlying'. For a group intent on rapid expansion there is going to be a sequence of yearly 'exceptional' costs.

I suspect there will also be a sequence of borrowings, placings etc. Hopefully, profit growth will outstrip the dilutive effects but I don't know enough about the business or the sector to make a judgement.

So I will continue to keep an eye on developments but stay on the sidelines for now.



Thanks for bringing it to my attention.

[dannys] 16/9/2009 09:44

daniel stewart new target price 1.18

[eater24] 15/9/2009 07:41

it certainly does look pretty good

[dannys] 15/9/2009 07:37

this all looks very good in my opinion.

[masurenguy] 15/9/2009 07:10

Good set of interims - sales, margins and earnings all up. Positive cashflow with cash unchanged at $4.5m even after additional investment !

RNS Number : 0350Z
Cryo-Save Group NV
15 September 2009

Revenues up 52%, profits up 17%

Cryo-Save Group N.V. (AIM: CRYO, 'Cryo-Save' or the 'Group'), Europe's leading adult stem cell storage bank, has published interim results for the six months ended 30 June 2009.

Financial highlights

Revenue up 52% to €18.6 million (1HY 2008: €12.2 million), reflecting strong organic and acquisitive growth

Gross margin increased to 71.1% (1HY 2008: 68.0%)

Underlying* EBITA up 123% to €2.9 million (1HY 2008: €1.3 million)

Underlying profit before taxation up 17% to €2.1 million (1HY 2008: €1.8 million)

Underlying earnings per share up 6% to 3.7 euro cents (1HY 2008: 3.5 cents)

Strong cash generation from operating activities €2.6 million

Net cash €4.5 million as at 30 June 2009 after substantial investment programme (31 December 2008: €4.5 million)

Financial sale and lease back of new Belgium building completed (€4.3 million)

Operational highlights

As at 30 June 2009 around 108,000 samples stored

Number of samples stored up 6% to 13,300 (1HY 2008: 12,500)

Three samples released for medical treatment

All time record with second quarter storage of 7,000 samples (Q2 2008: 6,600)

Strong organic growth in Spain, Italy and South Eastern Europe

*Underlying excludes the one-off write down of receivables on associate Cryo-Save Arabia (€0.9 million before taxation).

Marc Waeterschoot, Chief Executive, commented:

'Our investment and acquisition strategy, supported by increased prices over the last two years, is now really beginning to show good returns despite the current economic climate. 'Also notably we released three samples for use in medical treatments in the first half of this year, highlighting that the use of stem cells continues to widen. 'With the Q2 of this year showing our strongest sample storage numbers to date, our widening international spread of businesses, new products coming available plus our high operational gearing, means that we are well placed to continue to grow strongly and generate cash'

[dannys] 14/9/2009 17:11

results tomorrow........lets wait and see whats been going on.

[masurenguy] 12/9/2009 14:21

Some positive news prior to the interim results on Tuesday.

Cryo-Save India gets ISO 9001:2008 certification

Bangalore, Sep 10, 2009: Cryo–Save India, a part of Cryo-Save Group, Europe's largest adult stem cell storage bank, achieved a significant milestone with TUV Rheinland, Germany, conferring the India operations an ISO 9001:2008 certification. TUV Rheinland, a leading quality management systems registrar from Germany, certified Cryo-Save India after examining the lab on various parameters.

Cryo-Save India is dedicated to the highest quality standards and is the only company in its category to have received ISO 9001:2008 certification from TUV Rheinland, within such a short duration since commencement of its operations. The certification from TUV Rheinland helps to strengthen the processes and systems employed by Cryo-Save India, which include fully-automated systems that ensure no human intervention in storage and retrieval process along with a unique dual storage process.

"With years of delivering leading-edge solutions in the sphere of adult stem cell banking, Cryo-Save India has always been stringent on quality, thus taking the promise of uncompromised quality to its discerning customers. This certification strengthens our core proposition of delivering global standards through our processes and systems," said Mr Chandramouli, Managing Director, Cryo Save India.

As part of the ISO 9001 process, TUV performed on-site assessments, examining the Cryo-Save India documention procedures and audited its overall operations. To determine continued compliance with ISO 9001:2008, TUV would conduct periodically scheduled audits at Cryo–Save India and examine and monitor its business operations. Quality Council of India, the authority in India for ISO-related standards, too can conduct random audits to verify organization's compliance to declared practices.

[eater24] 11/9/2009 21:39

masurenguy/ danny's , i recently bought in here and watched this morning as a flow of sells appeared , interestingly the mm,s at one point increased both the offer and bid price which, made me feel it was a tree shake , it did fall back a little later but they wanted the shares!, results due tuesday any ideas what we might expect? if there are any dips i will buy more

[masurenguy] 11/9/2009 17:30

Over 120.000 shares bought in the last hour of trading at 84/85p.

[dannys] 11/9/2009 15:43

i,m in this for the long term so no intention of selling but will add on any dips if funds allow!

[masurenguy] 11/9/2009 10:40

This is down this morning mainly due to RHPS subscribers apparently being advised to take profits after the sharp rise in the share price was 'too good to ignore' following the Euronext listing announcement last week.

There were circa 60 Sell transactions in the first two and a half hours on AIM and Plus markets and one would assume that they will largely be cleared out by the end of today with just some overlap from any stragglers on Monday morning. The price is only marginally down by 2.4% so far but if it falls much further later in the day then it could be a good opportunity to top up.

Apparently RHPS originally recommended CRYO @69p on June 5th. I've checked back and the share price went up by 10% on the following trading day but then it drifted back down to 70p by the end of the week and subsequently declined to 51p over the following 4 weeks. That suggests that their Buy or Sell recommendations may only have a very short term impact on the share price.

[dannys] 09/9/2009 10:32

results next week and euro listing coming up should be very interesting times ahead...........anyone got any views on this company?
not too many postings here!

[masurenguy] 08/9/2009 18:40

The share price is up by more than 50% over the past 2 weeks with the obvious catalyst being last weeks announcement of their intention to list on Euronext.

[masurenguy] 06/9/2009 08:10

Some intelligent insight from Ambiorix1, a poster on iii, in relation to the proposed Euronext listing. The shares have now rallied by 24% in the two days following the company's announcement on Thursday morning (3/9).

"The additional listing on Euronext is good news. Some continental funds will add Cryo to their portfolio or own holdings. Delisting from Aim is going to be 'reviewed', but only in 2010, which sounds as not certain yet. Remember, some British Funds are important shareholders in Cryo, so Cryo could decide to hold on two listings, just as Sinclair Pharma [listed on Euronext and London]."

[masurenguy] 03/9/2009 10:22

Big tree shake this morning. With only 46.2m shares in issue it looks like the MMs want to accumulate some stock for subsequent buyers !

[masurenguy] 03/9/2009 10:19

Interesting development which indicates the extent of their ambitions. Euronext is the largest stock exchange in Europe who subsequently merged with the NYSE just under two years ago to form part of the largest stock market in the world. A Euronext listing will provide them with international exposure to investors and should enhance the credibility of their future expansion plans.

RNS Number : 4504Y
Cryo-Save Group NV
03 September 2009

Cryo-Save plans to list on Euronext

Cryo-Save Group N.V. (AIM: CRYO, "Cryo-Save"), Europe's leading stem cell
bank, plans to seek an additional listing on Euronext Amsterdam in the fourth
quarter of the current financial year to complement the Group's shares being
traded on AIM in London. Cryo-Save was admitted to trading on AIM on 6 November 2007.

Cryo-Save intends to review the need to maintain the AIM listing early
2010. Cryo-Save expects to make further announcements with regards to the
Euronext listing in due course.

Marc Waeterschoot, Chief Executive, commented: "We are looking to become listed on Euronext in Amsterdam. Being a Dutch company, with most of our business on the continent, a local listing should increase our visibility as well as liquidity."

[smarm] 29/8/2009 22:43

Mas - oh I see, thanks.

S

[masurenguy] 24/8/2009 08:30

Hi smarm,

The company was originally collecting and storing stem cells from umbilical cord blood (HSC) and they are licensed for this purpose in India. It is now proposing to add two other stem cell sources - from the cord tissue (MSC) and also from body fat (Cryo-lip) for the adult market.

My understanding of the article is that they have commenced the collection and storage of MSC free of charge, as distinct from HSC where they already charge, and that they will commence charging for MSC next month when they presumably expect to obtain licensed approval for this new stem cell source from the Indian government.